摘要
目的: 促进我国基本药物制度的完善,满足公众健康医疗需求。方法: 分析国家基本药物政策实施中可能面临的问题,提出意见与建议。结果: 我国基本药物法规体系虽已建立,但还落后于WHO倡导的目标。结论: 根据我国现有药物研发、生产和使用现状,学习WHO和其它国家成功的实践经验,赋予基本药物制度法律地位,建立适当的基本药物生产、采购、配送体系,使基本药物制度更加符合我国国情,更加完善。
Objective: To improve the national essential drug policy and to meet the public demand on the public health care. Methods: The problems existing in the essential medicine system in China were analyzed, and some countermeasures were come up with for the system. Results: The policy related to National Essential Drug List has been established in our country, but it still lags far behind the goal of essential drugs set by WTO. Conclusion: Considering the capacity on research and development of drugs, China should draw inspiration from WHO and other developed countries about their successful experiences on essential drugs to assign legal status for essential medicines and build up system of production, procurement and distribution of essential medicines according to the basic national situation of our country and finally establish the essential medicine system suitable to our country's condition.
出处
《药品评价》
CAS
2010年第6期16-20,共5页
Drug Evaluation